{"product_id":"ocular-disease-mechanisms-and-management-expert-consult-online-and-print-hardback-9780702029837","title":"Ocular Disease: Mechanisms and Management; Expert Consult - Online and Print (Hardback) 9780702029837","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eOcular Disease: Mechanisms and Management\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eExpert Consult - Online and Print\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThe best resource on the current understanding of how ophthalmic diseases start, progress, and are treated\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eLeonard A Levin (Author), Daniel M. Albert (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780702029837\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 10 March 2010\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e704 pages, Approx. 847 illustrations (708 in full color)\u003cbr\u003e21.6 x 27.9 x 3.7 cm, 2.31 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"Ocular Disease: Mechanisms and Management is invaluable in its emphasis on discussions of the pathophysiology of ocular disease. It provides an excellent and up-to-date overview of ophthalmic pathophysiology and bridges the gap between the basic science and the clinical practice of ophthalmology. The textbook is an invaluable resource for any ophthalmologist.\" \u003ci\u003eJAMA\u003c\/i\u003e, July 6, 2011—Vol 306, No. 1\u003c\/p\u003e \u003cp\u003e\"Do you look up PubMed on your lunch break to learn more about a patient you just saw? Are you a curious type, wanting to learn more than you really need to know to just get by? If so, then \u003ci\u003eOcular Disease: Mechanisms and Management\u003c\/i\u003e is the book for you. ...I am going to keep this book in my clinic. When I'm scratching my head about something I don't understand, I'll pull it down and review it.\" --Reviewed by Jim Hays, MD for \u003ci\u003eOcular Surgery News (Sept. 2010)\u003c\/i\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eOcular Disease—a newly introduced companion volume to the classic Adler’s Physiology of the Eye—correlates basic science and clinical management to describe the how and why of eye disease processes and the related best management protocols. Editors Leonard A. Levin and Daniel M. Albert—two of the world’s leading ophthalmic clinician-scientists—have recruited as contributors the most expert and experienced authorities available in each of the major areas of ophthalmic disease specific to ophthalmology: retina, cornea, cataract, glaucoma, uveitis, and more. The concise chapter structure features liberal use of color—with 330 full-color line artworks, call-out boxes, summaries, and schematics for easy navigation and understanding. In print and online at expertconsult.com, this comprehensive resource provides you with a better and more practical understanding of the science behind eye disease and its relation to treatment.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eIncludes access to the fully searchable text online at expertconsult.com, along with images and references.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCovers all areas of disease in ophthalmology including retina, cornea, cataract, glaucoma, and uveitis for the comprehensive information you need for managing clinical cases.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePresents a unique and pragmatic blend of necessary basic science and clinical application to serve as a clinical guide to understanding the cause and rational management of ocular disease.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures 330 full-color line artworks that translate difficult concepts and discussions into concise schematics for improved understanding and comprehension.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eProvides the expert advice of internationally recognized editors with over 40 years of experience together with a group of world class contributors in basic science and clinical ophthalmology.\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eSECTION 1 Cornea\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e1. Loss of corneal transparency \u003c\/p\u003e \u003cp\u003eRussell L McCally \u003c\/p\u003e \u003cp\u003e2. Abnormalities of corneal wound healing \u003c\/p\u003e \u003cp\u003eAudrey M Bernstein \u003c\/p\u003e \u003cp\u003e3. Wound healing after laser in situ keratomileusis and photorefractive keratectomy \u003c\/p\u003e \u003cp\u003eFabricio Witzel de Medeiros and Steven E Wilson \u003c\/p\u003e \u003cp\u003e4. Genetics and mechanisms of hereditary corneal dystrophies \u003c\/p\u003e \u003cp\u003eJohn D Gottsch \u003c\/p\u003e \u003cp\u003e5. Fuchs’ endothelial corneal dystrophy \u003c\/p\u003e \u003cp\u003eVinay Gutti, David S Bardenstein, Sudha Iyengar, and Jonathan H Lass \u003c\/p\u003e \u003cp\u003e6. Keratoconus \u003c\/p\u003e \u003cp\u003eM Cristina Kenney and Ronald N Gaster \u003c\/p\u003e \u003cp\u003e7. Infectious keratitis \u003c\/p\u003e \u003cp\u003eMichael S Gilmore, Susan R Heimer, and Ai Yamada \u003c\/p\u003e \u003cp\u003e8. Corneal graft rejection\u003c\/p\u003e \u003cp\u003eDaniel R Saban, Mohammad H Dastjerdi, and Reza Dana\u003c\/p\u003e \u003cp\u003e9. Corneal edema\u003c\/p\u003e \u003cp\u003eDaniel G Dawson and Henry F Edelhauser \u003c\/p\u003e \u003cp\u003e10. Corneal angiogenesis and lymphangiogenesis \u003c\/p\u003e \u003cp\u003eChih-Wei Wu, David Ellenberg, and Jin-Hong Chang \u003c\/p\u003e \u003cp\u003e11. Ocular surface restoration \u003c\/p\u003e \u003cp\u003eJulie T Daniels, Genevieve A Secker, and Alex J Shortt \u003c\/p\u003e \u003cp\u003e12. Herpetic keratitis\u003c\/p\u003e \u003cp\u003ePranita P Sarangi and Barry T Rouse \u003c\/p\u003e \u003cp\u003e13. Ocular allergy\u003c\/p\u003e \u003cp\u003eNeal P Barney, Ellen B Cook, James L Stahl, and Frank M Graziano \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSECTION 2 Dry eye\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e14. The lacrimal gland and dry-eye disease\u003c\/p\u003e \u003cp\u003eDarlene A Dartt \u003c\/p\u003e \u003cp\u003e15. Immune mechanisms of dry-eye disease \u003c\/p\u003e \u003cp\u003eAustin K Mircheff and Joel E Schechter \u003c\/p\u003e \u003cp\u003e16. Disruption of tear ?lm and blink dynamics\u003c\/p\u003e \u003cp\u003eJianhua Wang and Anuj Chauhan \u003c\/p\u003e \u003cp\u003e17. Abnormalities of eyelid and tear ?lm lipid \u003c\/p\u003e \u003cp\u003eGary N Foulks and Douglas Borchman \u003c\/p\u003e \u003cp\u003e18 Dry eye: abnormalities of tear ?lm mucins \u003c\/p\u003e \u003cp\u003eAnn-Christin Albertsmeyer and Ilene K Gipson \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSECTION 3 Glaucoma\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e19. Steroid-induced glaucoma \u003c\/p\u003e \u003cp\u003eAbbot F Clark, Xinyu Zhang, and Thomas Yorio \u003c\/p\u003e \u003cp\u003e20. Biomechanical changes of the optic disc \u003c\/p\u003e \u003cp\u003eIan A Sigal, Michael D Roberts, Michael JA Girard, Claude F Burgoyne, and J Crawford Downs \u003c\/p\u003e \u003cp\u003e21. Pigmentary dispersion syndrome and glaucoma\u003c\/p\u003e \u003cp\u003eMichael G Anderson \u003c\/p\u003e \u003cp\u003e22. Abnormal trabecular meshwork out?ow \u003c\/p\u003e \u003cp\u003ePaul A Knepper and Beatrice YJT Yue \u003c\/p\u003e \u003cp\u003e23. Pressure-induced optic nerve damage\u003c\/p\u003e \u003cp\u003eJames C Tsai \u003c\/p\u003e \u003cp\u003e24. Exfoliation (pseudoexfoliation) syndrome \u003c\/p\u003e \u003cp\u003eRobert Ritch and Ursula Schlötzer-Schrehardt \u003c\/p\u003e \u003cp\u003e25. Angle closure glaucoma \u003c\/p\u003e \u003cp\u003eShamira Perera, Nishani Amerasinghe, and Tin Aung\u003c\/p\u003e \u003cp\u003e26. Central nervous system changes in glaucoma\u003c\/p\u003e \u003cp\u003eYeni N Yücel and Neeru Gupta \u003c\/p\u003e \u003cp\u003e27. Retinal ganglion cell death in glaucoma \u003c\/p\u003e \u003cp\u003eHeather R Pelzel and Robert W Nickells \u003c\/p\u003e \u003cp\u003e28. Wound-healing responses to glaucoma surgery\u003c\/p\u003e \u003cp\u003eStelios Georgoulas, Annegret Dahlmann-Noor, Stephen Brocchini, and Peng Tee Khaw \u003c\/p\u003e \u003cp\u003e29. Blood ?owchanges in glaucoma \u003c\/p\u003e \u003cp\u003eLeopold Schmetterer and Mark Lesk \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSECTION 4 Lens\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e30. Biochemical mechanisms of age-related cataract\u003c\/p\u003e \u003cp\u003eDavid C Beebe, Ying-Bo Shui, and Nancy M Holekamp \u003c\/p\u003e \u003cp\u003e31. Posterior capsule opaci?cation \u003c\/p\u003e \u003cp\u003eJudith West-Mays and Heather Sheardown\u003c\/p\u003e \u003cp\u003e32. Diabetes-associated cataracts \u003c\/p\u003e \u003cp\u003ePeter F Kador \u003c\/p\u003e \u003cp\u003e33. Steroid-induced cataract\u003c\/p\u003e \u003cp\u003eAbbas Samadi \u003c\/p\u003e \u003cp\u003e34. Presbyopia\u003c\/p\u003e \u003cp\u003eJane F Koretz \u003c\/p\u003e \u003cp\u003e35. Restoration of accommodation\u003c\/p\u003e \u003cp\u003eStephen D McLeod and Michelle Trager Cabrera\u003c\/p\u003e \u003cp\u003e36. Intraoperative ?oppy iris syndrome\u003c\/p\u003e \u003cp\u003eAmy Lin and Roger F Steinert \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSECTION 5 Neuro-ophthalmology\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e37. Optic neuritis \u003c\/p\u003e \u003cp\u003eJohn R Guy and Xiaoping Qi \u003c\/p\u003e \u003cp\u003e38. Abnormal ocular motor control \u003c\/p\u003e \u003cp\u003eJames A Sharpe and Arun Sundaram \u003c\/p\u003e \u003cp\u003e39. Idiopathic intracranial hypertension (idiopathic pseudotumor cerebri) \u003c\/p\u003e \u003cp\u003eDeborah M Grzybowski and Martin Lubow \u003c\/p\u003e \u003cp\u003e40. Giant cell arteritis\u003c\/p\u003e \u003cp\u003eLynn K Gordon \u003c\/p\u003e \u003cp\u003e41. Ischemic optic neuropathy \u003c\/p\u003e \u003cp\u003eHelen Danesh-Meyer \u003c\/p\u003e \u003cp\u003e42. Optic nerve axonal injury \u003c\/p\u003e \u003cp\u003eDaniela Toffoli and Leonard A Levin \u003c\/p\u003e \u003cp\u003e43. Leber’s hereditary optic neuropathy \u003c\/p\u003e \u003cp\u003eAlfredo Sadun and Alice Kim \u003c\/p\u003e \u003cp\u003e44. Optic atrophy \u003c\/p\u003e \u003cp\u003eNathan T Tagg and Randy H Kardon \u003c\/p\u003e \u003cp\u003e45. Nystagmus\u003c\/p\u003e \u003cp\u003eFrank Proudlock and Irene Gottlob \u003c\/p\u003e \u003cp\u003e46. Toxic optic nerve neuropathies\u003c\/p\u003e \u003cp\u003eFT \"Fritz\" Fraunfelder and FW \"Rick\" Fraunfelder \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSECTION 6 Oncology\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e47. Uveal melanoma\u003c\/p\u003e \u003cp\u003eZélia MS Corrêa and J William Harbour \u003c\/p\u003e \u003cp\u003e48. Genetics of hereditary retinoblastoma \u003c\/p\u003e \u003cp\u003eAlejandra G de Alba Campomanes and Joan M O’Brien \u003c\/p\u003e \u003cp\u003e49. Molecular basis of low-penetrance retinoblastoma \u003c\/p\u003e \u003cp\u003eKatie Matatall and J William Harbour \u003c\/p\u003e \u003cp\u003e50. Vasculogenic mimicry \u003c\/p\u003e \u003cp\u003eRobert Folberg and Andrew J Maniotis \u003c\/p\u003e \u003cp\u003e51. Treatment of choroidal melanoma\u003c\/p\u003e \u003cp\u003eAimee V Chappelow and Andrew P Schachat \u003c\/p\u003e \u003cp\u003e52. Sebaceous cell carcinoma \u003c\/p\u003e \u003cp\u003eAlon Kahana, Jonathan T Pribila, Christine C Nelson, and Victor M Elner \u003c\/p\u003e \u003cp\u003e53. Neuro?bromatosis \u003c\/p\u003e \u003cp\u003eRobert Listernick and David H Gutmann \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSECTION 7 Other\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e54 Phthisis bulbi \u003c\/p\u003e \u003cp\u003eIngo Schmack, Hans E Völcker, and Hans E Grossniklaus \u003c\/p\u003e \u003cp\u003e55. Myopia\u003c\/p\u003e \u003cp\u003eTerri L Young \u003c\/p\u003e \u003cp\u003e56. Pathogenesis of Graves’ ophthalmopathy\u003c\/p\u003e \u003cp\u003eA Reagan Schiefer and Rebecca S Bahn \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSECTION 8 Pediatrics\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e57. Duane syndrome \u003c\/p\u003e \u003cp\u003eJoseph L Demer \u003c\/p\u003e \u003cp\u003e58. Amblyopia\u003c\/p\u003e \u003cp\u003eRobert F Hess and Nigel Daw \u003c\/p\u003e \u003cp\u003e59 Strabismus \u003c\/p\u003e \u003cp\u003eChristopher S von Bartheld, Scott A Croes, and L Alan Johnson \u003c\/p\u003e \u003cp\u003e60. Albinism\u003c\/p\u003e \u003cp\u003eGerald F Cox and Anne B Fulton \u003c\/p\u003e \u003cp\u003e61. Aniridia\u003c\/p\u003e \u003cp\u003eElias I Traboulsi \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSECTION 9 Retina\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e62. Color vision defects \u003c\/p\u003e \u003cp\u003eMaureen Neitz and Jay Neitz \u003c\/p\u003e \u003cp\u003e63. Acute retinal vascular occlusive disorders \u003c\/p\u003e \u003cp\u003eSohan Singh Hayreh \u003c\/p\u003e \u003cp\u003e64. Retinal photic injury: laboratory and clinical ?ndings \u003c\/p\u003e \u003cp\u003eDaniel Organisciak and Marco Zarbin \u003c\/p\u003e \u003cp\u003e65. Vascular damage in diabetic retinopathy \u003c\/p\u003e \u003cp\u003eTimothy S Kern and Suber Huang \u003c\/p\u003e \u003cp\u003e66. Neovascularization in diabetic retinopathy \u003c\/p\u003e \u003cp\u003eCorey B Westerfeld and Joan W Miller \u003c\/p\u003e \u003cp\u003e67. Diabetic macular edema \u003c\/p\u003e \u003cp\u003ePascale Massin, Michel Paques, and Jean-Antoine Pournaras\u003c\/p\u003e \u003cp\u003e68. Dry age-related macular degeneration and age-related macular degeneration pathogenesis\u003c\/p\u003e \u003cp\u003eMarco Zarbin and Janet S Sunness \u003c\/p\u003e \u003cp\u003e69. Neovascular age-related macular degenerationDavid E Lederer, Scott W Cousins, and Karl G Csaky\u003c\/p\u003e \u003cp\u003e70. Inhibition of \u003c\/p\u003e \u003cp\u003eAnthony P Adamis and Adrienne Berman \u003c\/p\u003e \u003cp\u003e71. Retinal detachment \u003c\/p\u003e \u003cp\u003eSteven K Fisher and Geoffrey P Lewis \u003c\/p\u003e \u003cp\u003e72. Retinopathy of prematurity \u003c\/p\u003e \u003cp\u003eMary Elizabeth Hartnett and Cynthia A Toth \u003c\/p\u003e \u003cp\u003e73. Retinal energy metabolism \u003c\/p\u003e \u003cp\u003eRobert A Linsenmeier \u003c\/p\u003e \u003cp\u003e74. Retinitis pigmentosa and related disorders\u003c\/p\u003e \u003cp\u003eEric A Pierce \u003c\/p\u003e \u003cp\u003e75 Visual prostheses and other assistive devices \u003c\/p\u003e \u003cp\u003eMuhammad Ali Memon and Joseph F Rizzo III \u003c\/p\u003e \u003cp\u003e76. Paraneoplastic retinal degeneration \u003c\/p\u003e \u003cp\u003eGrazyna Adamus \u003c\/p\u003e \u003cp\u003e77. Cellular repopulation of the retina \u003c\/p\u003e \u003cp\u003eBudd AL Tucker, Michael J Young, and Henry J Klassen \u003c\/p\u003e \u003cp\u003e78. Proliferative vitreoretinopathy \u003c\/p\u003e \u003cp\u003eClyde Guidry \u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSECTION 10 Uveitis\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e79. Immunologic mechanisms of uveitis \u003c\/p\u003e \u003cp\u003eSteven Yeh, Zhuqing Li, and Robert B Nussenblatt \u003c\/p\u003e \u003cp\u003e80. Herpesvirus retinitis \u003c\/p\u003e \u003cp\u003eSally S Atherton and Mei Zheng \u003c\/p\u003e \u003cp\u003e81. Sympathetic ophthalmia \u003c\/p\u003e \u003cp\u003eMirunalini Kumaradas and Narsing A Rao \u003c\/p\u003e \u003cp\u003e82. Scleritis \u003c\/p\u003e \u003cp\u003eSrilakshmi M Sharma and James T Rosenbaum \u003c\/p\u003e \u003cp\u003e83 Infectious uveitis \u003c\/p\u003e \u003cp\u003ePooja Bhat, Allen Tony Jackson, and C Stephen Foster \u003c\/p\u003e \u003cp\u003e84. Ocular sarcoidosis \u003c\/p\u003e \u003cp\u003eRussell N Van Gelder and Suzanne M Dintzis \u003c\/p\u003e  \u003cp\u003eIndex\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Ophthalmology [\u003ca title=\"See our other books on Ophthalmology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Ophthalmology%20%5BMJQ%5D%22\"\u003eMJQ\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46651549516056,"sku":"9780702029837","price":87.79,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780702029837.jpg?v=1694113754","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/ocular-disease-mechanisms-and-management-expert-consult-online-and-print-hardback-9780702029837","provider":"Freshly Printed Books","version":"1.0","type":"link"}